tirzepatide and kidney damage SURPASS-4: slows disease in adults with type 2 diabetes, CV risk Join a trial on tirzepatide
Description
Mounjaro is a weight loss injection manufactured by Eli Lilly that targets obesity through its dual action as both a GLP-1 and GIP agonist.
Clinically, tirzepatide has shown its potential in not only reducing body []
But are these approaches effective and safe for teens, too?
It has become easily accessible, and widely available to most people, which has been AMAZING
Methods In this open-label, single-center, casecontrol pilot study, patients with IIH (pwIIH) and a body mass index (BMI) of30 kg/m2 were offered to receive a GLP-1-RA (semaglutide, liraglutide) in addition to the usual care weight management (UCWM)
